Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

The Lancet Oncology

Topics

Medicine

Cancer Oncology

Epidemiology

Internal Medicine

Surgery

Show all topics

DOI

10.1016/s1470-2045(19)30395-x

License

CC-BY

Other Formats

PDF